IP Library Granted Patent US 7,848,801
Granted Patent B2
US 7,848,801 · App. 11/618,558 · Granted Dec 7, 2010

Iontophoretic systems, devices, and methods of delivery of active agents to biological interface

Assignee: TTI ellebeau, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,848,801
App. No.
11/618,558
Granted
Dec 7, 2010
Kind
B2
Abstract

A transdermal delivery device to passively deliver active agents to a biological interface includes an active agent reservoir comprising a first active agent of a first polarity; an outer active agent membrane taking the form of an ion-exchange membrane of a second polarity, an interfacial layer having a plurality of freely diffusible monovalent co-ions of the first polarity and having a first side adjacent to the outer active agent membrane and a second side configured to contact a biological interface.

Claims (12)

1. A transdermal delivery device to passively deliver active agents to a biological interface, comprising:

an active agent reservoir comprising a first active agent of a first polarity;

an outer active agent membrane comprising a second active agent of the first polarity distributed therein, the outer active agent membrane taking the form of an ion-exchange membrane of a second polarity; and

an interfacial layer having a first side adjacent to the outer active agent membrane and a second side configured to contact a biological interface, the interfacial layer comprising a plurality of freely diffusible monovalent co-ions of the first polarity.

2. The transdermal delivery device of claim 1 wherein the interfacial layer comprises a porous membrane material.

3. The transdermal delivery device of claim 2 wherein the interfacial layer takes the form of a gel or an adhesive.

4. The transdermal delivery device of claim 1 wherein the first polarity of the monovalent co-ions of the interfacial layer being opposite to the second polarity of the ion-exchange membrane.

5. The transdermal delivery device of claim 1 wherein the interfacial layer has a thickness of less than about 100 μm.

6. The transdermal delivery device of claim 1 wherein the first and the second active agents are the same.

7. The transdermal delivery device of claim 1 wherein the plurality of monovalent co-ions have lipophilic counter-ions.

8. The transdermal delivery device of claim 1 wherein the monovalent co-ions have a higher affinity than the second active agent has for the outer active agent membrane.

9. The transdermal delivery device of claim 1 wherein the monovalent co-ions are capable of diffusing to the outer active agent membrane and displacing the second active agent distributed therein.

Assignments (6)
RESCISSION OF PRIOR ASSIGNMENT Recorded Mar 10, 2008
From: TRANSCU LTD.
To: TTI ELLEBEAU, INC.
Reel/Frame 020626/0021 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 12, 2007
From: TTI ELLEBEAU, INC.
To: TRANSCU LTD.
Reel/Frame 020236/0175 →
CHANGE OF NAME Recorded Dec 7, 2007
From: ELLEBEAU, INC.
To: TTI ELLEBEAU, INC.
Reel/Frame 020214/0336 →
MERGER Recorded Dec 5, 2007
From: TRANSCUTANEOUS TECHNOLOGIES, INC.
To: ELLEBEAU, INC.
Reel/Frame 020200/0803 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 17, 2007
From: CARTER, DARRICK; SMITH, GREGORY A.
To: TRANSCUTANEOUS TECHNOLOGIES INC.
Reel/Frame 019977/0715 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 16, 2007
From: CARTER, DARRICK
To: TRANSCUTANEOUS TECHNOLOGIES INC.
Reel/Frame 019971/0157 →
Continuity (2)
Provisional Application 6075539100 · Dec 30, 2005
Related Publication 20080027369A1 · Jan 31, 2008